Celcuity (CELC) Accumulated Expenses (2016 - 2025)
Celcuity (CELC) reported Accumulated Expenses of $27.3 million for Q3 2025, up 60.7% on a YoY basis from $17.0 million in Q3 2024, and down 4.77% quarter-over-quarter from $28.6 million in Q2 2025.
Celcuity (CELC) Accumulated Expenses (2016 - 2025) Analysis & Trends
Celcuity has reported Accumulated Expenses for 10 years, with the latest figure at $27.3 million in Q3 2025.
- For the quarter ending Q3 2025, Accumulated Expenses rose 60.7% year-over-year to $27.3 million; the trailing twelve-month figure through Sep 2025 stood at $27.3 million (up 60.7% YoY), and the FY2024 full-year result was $22.2 million, up 148.51% from the prior year.
- Accumulated Expenses for Q3 2025 stood at $27.3 million, down from $28.6 million in the prior quarter.
- The five-year high for Accumulated Expenses was $28.6 million in Q2 2025, with the low at $438477.0 in Q4 2021.
- Historically, Accumulated Expenses has averaged $9.2 million across 5 years, with a median of $3.9 million in 2023.
- Annual changes were most pronounced in 2021 — Accumulated Expenses gained 7.55% — and 2023, when it surged 860.71%.
- Celcuity's Accumulated Expenses stood at $438477.0 in 2021, then surged by 111.92% to $929216.0 in 2022, then surged by 860.71% to $8.9 million in 2023, then jumped by 148.51% to $22.2 million in 2024, then rose by 22.96% to $27.3 million in 2025.
- The last three Accumulated Expenses figures came in at $27.3 million (Q3 2025), $28.6 million (Q2 2025), and $22.8 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 27.28 Mn |
| Jun 30, 2025 | 28.64 Mn |
| Mar 31, 2025 | 22.82 Mn |
| Dec 31, 2024 | 22.19 Mn |
| Sep 30, 2024 | 16.97 Mn |
| Jun 30, 2024 | 13.15 Mn |
| Mar 31, 2024 | 11.24 Mn |
| Dec 31, 2023 | 8.93 Mn |
| Sep 30, 2023 | 6.89 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 3.04 Mn |
| Dec 31, 2022 | 929,216.00 |
| Sep 30, 2022 | 3.28 Mn |
| Jun 30, 2022 | 1.68 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 438,477.00 |
| Sep 30, 2021 | 879,851.00 |
| Jun 30, 2021 | 729,672.00 |
| Mar 31, 2021 | 660,849.00 |
| Dec 31, 2020 | 137,020.00 |